Quick answers
- What is Attero?
- Attero is a brand name of Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene), a prescription medicine. The FDA NDC Directory lists 1 Attero product in 1 strength and form.
- Who makes Attero?
- Cosette Pharms NC holds the FDA application for Attero (ANDA210765, approved May 11, 2020).
- Is there a generic or store brand of Attero?
- Other products of Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene) are listed with the FDA, but none in exactly the same strength and form as a Attero product.
- Has Attero been recalled?
- No recall linked to Attero products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Attero is
Each Attero product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene) · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| betamethasone dipropionate 0.05% · calcipotriene 0.005% solution (topical) | Attero | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Calcipotriene and betamethasone dipropionate (betamethasone dipropionate / calcipotriene) →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA210765 | Cosette Pharms NC | May 11, 2020 | 1 |
Companies that list Attero
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Attero products.
- Perfero Pharma, Inc.1 product
Recalls
No recall linked to Attero products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.